ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
41 hedge funds and large institutions have $8.19M invested in Albireo Pharma Inc in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
80% less call options, than puts
Call options by funds: $16K | Put options by funds: $81K
Holders
41
Holding in Top 10
–
Calls
$16K
Puts
$81K
Top Buyers
| 1 | +$2.4M | |
| 2 | +$520K | |
| 3 | +$115K | |
| 4 |
FMA
FNY Managed Accounts
New York
|
+$61.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35K |
Top Sellers
| 1 | -$887K | |
| 2 | -$311K | |
| 3 | -$136K | |
| 4 |
CC
Cannell & Co
New York
|
-$69.2K |
| 5 |
D.E. Shaw & Co
New York
|
-$27.2K |